Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-07

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multiple system atrophy (MSA) is a rare neurodegenerative disorder that leads to major disability, forcing patients and caregivers to adapt their environment and lifestyle. Once they receive the diagnosis, patients and caregivers need to understand the symptoms, cope with them, to digest the diagnosis... All these needs are not completely addressed by the current model of care so we created a therapeutic educational program (TEP) program that will last 12 months, involving both patients and caregivers, including a mixed model of in-person visits and continuous on-line activities. Our project aims to target early MSA patients and their caregivers, proposing to test the feasibility (primary objective) of an innovative therapeutic educational program (TEP) for MSA patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life

NCT01796314

Alzheimer Disease

COMPLETED NA

Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy

NCT04965922

Multiple System Atrophy

COMPLETED NA

Assessment of Teleconsulting in Nursing Homes

NCT02157740

Functionally-Impaired Elderly

UNKNOWN

Effectiveness and Organizational Conditions of Effectiveness of Telemedicine in Establishments Providing Care for the Dependent Elderly

NCT03486977

Health Services for the Aged

COMPLETED

Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia

NCT04957537

Primary Progressive Aphasia

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The announcement of MSA diagnosis may provoke a shock in patients and their relatives. Educational programs in neurodegenerative diseases, such as Parkinson's disease (PD), offer patients and caregivers structured skills in disease knowledge, expertise, and management. Those programs may result in an improvement of patients' quality of life (QoL), empowering patients and their caregivers to deal with psychosocial challenges. Additionally, it has been shown that educational programs positively impact the perceived health of PD patients without increasing medical costs. There is no educational program for MSA patients. This is the reason why we created the first therapeutic educational program (TEP) for MSA patients and caregivers, including a mix model of in person visits and online classes and virtual activities. Herein, we aim to target early MSA patients (time to diagnosis \< 1 year) and their caregivers, proposing to test the feasibility of this TEP. The program will last 12 months, involving both patients and caregivers, including a mixed model of in-person visits (at baseline and 12 months) and continuous on-line activities (learning situations, questionnaires, quizzes, videos, and interactive exercises).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple System Atrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental patients

MSA patients included in the therapeutic education program

Group Type EXPERIMENTAL

Therapeutic Education Program (TEP)

Intervention Type OTHER

the TEP lasts 12 months, being structured into 6 modules.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapeutic Education Program (TEP)

the TEP lasts 12 months, being structured into 6 modules.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have had a clinically probable diagnosis of MSA within the last 3 years or clinically established within the last year
* Presence of a caregiver defined as a spouse, son/daughter or relative who lives with or sees the patient on a regular basis, i.e. at least three times a week.

Exclusion Criteria

* Patients and/or caregiver unable to give consent
* Patients without access to an internet network or without the material means to access the distance learning modules
* Patients with a life expectancy of less than one year
* Patients with legal guardians, curators, or legal protection
* Patients not affiliated to a social security system
* Patients in a period of exclusion from another study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No